Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 261

Similar articles for PubMed (Select 10978352)

1.
2.

Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene.

Lage PA, Albuquerque C, Sousa RG, Cravo ML, Salazar M, Francisco I, Maia L, Claro I, Suspiro A, Rodrigues P, Raposo H, Fidalgo PA, Nobre-Leitão C.

Cancer. 2004 Jul 1;101(1):172-7.

3.

Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain.

Caldes T, Godino J, de la Hoya M, Garcia Carbonero I, Perez Segura P, Eng C, Benito M, Diaz-Rubio E.

Int J Cancer. 2002 Apr 10;98(5):774-9.

PMID:
11920650
4.

Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer.

Bapat BV, Madlensky L, Temple LK, Hiruki T, Redston M, Baron DL, Xia L, Marcus VA, Soravia C, Mitri A, Shen W, Gryfe R, Berk T, Chodirker BN, Cohen Z, Gallinger S.

Hum Genet. 1999 Feb;104(2):167-76.

PMID:
10190329
5.

Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.

Wijnen JT, Vasen HF, Khan PM, Zwinderman AH, van der Klift H, Mulder A, Tops C, Møller P, Fodde R.

N Engl J Med. 1998 Aug 20;339(8):511-8.

6.

Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.

Bonis PA, Trikalinos TA, Chung M, Chew P, Ip S, DeVine DA, Lau J.

Evid Rep Technol Assess (Full Rep). 2007 May;(150):1-180. Review.

7.

Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.

Wagner A, Barrows A, Wijnen JT, van der Klift H, Franken PF, Verkuijlen P, Nakagawa H, Geugien M, Jaghmohan-Changur S, Breukel C, Meijers-Heijboer H, Morreau H, van Puijenbroek M, Burn J, Coronel S, Kinarski Y, Okimoto R, Watson P, Lynch JF, de la Chapelle A, Lynch HT, Fodde R.

Am J Hum Genet. 2003 May;72(5):1088-100. Epub 2003 Mar 25.

8.

Ten novel MSH2 and MLH1 germline mutations in families with HNPCC.

Krüger S, Bier A, Plaschke J, Höhl R, Aust DE, Kreuz FR, Pistorius SR, Saeger HD, Rothhammer V, Al-Taie O, Schackert HK.

Hum Mutat. 2004 Oct;24(4):351-2.

PMID:
15365996
9.

Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer.

Raedle J, Trojan J, Brieger A, Weber N, Schäfer D, Plotz G, Staib-Sebler E, Kriener S, Lorenz M, Zeuzem S.

Ann Intern Med. 2001 Oct 16;135(8 Pt 1):566-76.

PMID:
11601928
10.

Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis.

de Leon MP, Pedroni M, Benatti P, Percesepe A, Di Gregorio C, Foroni M, Rossi G, Genuardi M, Neri G, Leonardi F, Viel A, Capozzi E, Boiocchi M, Roncucci L.

Gut. 1999 Jul;45(1):32-8.

11.

Hereditary non-polyposis colorectal cancer (HNPCC): phenotype-genotype correlation between patients with and without identified mutation.

Bisgaard ML, Jäger AC, Myrhøj T, Bernstein I, Nielsen FC.

Hum Mutat. 2002 Jul;20(1):20-7.

PMID:
12112654
12.

Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.

Plaschke J, Engel C, Krüger S, Holinski-Feder E, Pagenstecher C, Mangold E, Moeslein G, Schulmann K, Gebert J, von Knebel Doeberitz M, Rüschoff J, Loeffler M, Schackert HK.

J Clin Oncol. 2004 Nov 15;22(22):4486-94. Epub 2004 Oct 13.

13.

Genetic testing for hereditary nonpolyposis colorectal cancer.

Hoedema R, Monroe T, Bos C, Palmer S, Kim D, Marvin M, Luchtefeld M.

Am Surg. 2003 May;69(5):387-91; discussion 391-2.

PMID:
12769209
14.

Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer.

Mangold E, Pagenstecher C, Friedl W, Mathiak M, Buettner R, Engel C, Loeffler M, Holinski-Feder E, Müller-Koch Y, Keller G, Schackert HK, Krüger S, Goecke T, Moeslein G, Kloor M, Gebert J, Kunstmann E, Schulmann K, Rüschoff J, Propping P.

Int J Cancer. 2005 Sep 20;116(5):692-702.

PMID:
15849733
15.

Spectrum of germ-line MLH1 and MSH2 mutations in Austrian patients with hereditary nonpolyposis colorectal cancer.

Wolf B, Henglmueller S, Janschek E, Ilencikova D, Ludwig-Papst C, Bergmann M, Mannhalter C, Wrba F, Karner-Hanusch J.

Wien Klin Wochenschr. 2005 Apr;117(7-8):269-77.

PMID:
15926618
16.

Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.

Caldés T, Godino J, Sanchez A, Corbacho C, De la Hoya M, Lopez Asenjo J, Saez C, Sanz J, Benito M, Ramon Y Cajal S, Diaz-Rubio E.

Oncol Rep. 2004 Sep;12(3):621-9.

PMID:
15289847
17.

Seven novel MLH1 and MSH2 germline mutations in hereditary nonpolyposis colorectal cancer.

Krüger S, Plaschke J, Pistorius S, Jeske B, Haas S, Krämer H, Hinterseher I, Bier A, Kreuz FR, Theissig F, Saeger HD, Schackert HK.

Hum Mutat. 2002 Jan;19(1):82.

PMID:
11754112
18.

Clinical and molecular characteristics of hereditary non-polyposis colorectal cancer families in Southeast Asia.

Lee SC, Guo JY, Lim R, Soo R, Koay E, Salto-Tellez M, Leong A, Goh BC.

Clin Genet. 2005 Aug;68(2):137-45.

PMID:
15996210
19.

Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing.

Terdiman JP, Gum JR Jr, Conrad PG, Miller GA, Weinberg V, Crawley SC, Levin TR, Reeves C, Schmitt A, Hepburn M, Sleisenger MH, Kim YS.

Gastroenterology. 2001 Jan;120(1):21-30.

PMID:
11208710
20.

Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes.

Wang Y, Friedl W, Lamberti C, Jungck M, Mathiak M, Pagenstecher C, Propping P, Mangold E.

Int J Cancer. 2003 Feb 20;103(5):636-41.

PMID:
12494471
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk